| Year |
Citation |
Score |
| 2020 |
Oldrini B, Vaquero-Siguero N, Mu Q, Kroon P, Zhang Y, Galán-Ganga M, Bao Z, Wang Z, Liu H, Sa JK, Zhao J, Kim H, Rodriguez-Perales S, Nam DH, Verhaak RGW, ... Rabadan R, et al. MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas. Nature Communications. 11: 3883. PMID 32753598 DOI: 10.1038/S41467-020-17717-0 |
0.316 |
|
| 2020 |
Rabadán R, Mohamedi Y, Rubin U, Chu T, Alghalith AN, Elliott O, Arnés L, Cal S, Obaya ÁJ, Levine AJ, Cámara PG. Identification of relevant genetic alterations in cancer using topological data analysis. Nature Communications. 11: 3808. PMID 32732999 DOI: 10.1038/S41467-020-17659-7 |
0.382 |
|
| 2020 |
Fiore D, Cappelli LV, Zumbo P, Phillips JM, Liu Z, Cheng S, Yoffe L, Ghione P, Di Maggio F, Dogan A, Khodos I, de Stanchina E, Casano J, Kayembe C, Tam W, ... ... Rabadan R, et al. A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical Discoveries. Cancers. 12. PMID 32560455 DOI: 10.3390/Cancers12061603 |
0.343 |
|
| 2020 |
Kane JR, Zhao J, Tsujiuchi T, Laffleur B, Arrieta VA, Mahajan A, Rao G, Mela A, Dmello C, Chen L, Zhang DY, Gonzalez-Buendia E, Lee-Chang C, Xiao T, Rothschild G, ... ... Rabadan R, et al. CD8 T-cell-mediated immunoediting influences genomic evolution and immune evasion in murine gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32430477 DOI: 10.1158/1078-0432.Ccr-19-3104 |
0.313 |
|
| 2020 |
Liu Z, Zhang J, Sun Y, Perea-Chamblee TE, Manley JL, Rabadan R. Pan-cancer analysis identifies mutations in that recapitulate mutant SF3B1 splicing dysregulation. Proceedings of the National Academy of Sciences of the United States of America. PMID 32332164 DOI: 10.1073/Pnas.1922622117 |
0.368 |
|
| 2020 |
Liu Z, Yoshimi A, Wang J, Cho H, Chun-Wei Lee S, Ki M, Bitner L, Chu T, Shah H, Liu B, Mato AR, Ruvolo P, Fabbri G, Pasqualucci L, Abdel-Wahab O, ... Rabadan R, et al. Mutations in the RNA splicing factor SF3B1 promote tumorigenesis through MYC stabilization. Cancer Discovery. PMID 32188705 DOI: 10.1158/2159-8290.Cd-19-1330 |
0.371 |
|
| 2020 |
Gartrell-Corrado RD, Chen AX, Rizk EM, Marks DK, Bogardus MH, Hart TD, Silverman AM, Bayan CY, Finkel GG, Barker LW, Komatsubara KM, Carvajal RD, Horst BA, Chang R, Monod A, ... Rabadan R, et al. Linking transcriptomic and imaging data defines features of a favorable tumor immune microenvironment and identifies a combination biomarker for primary melanoma. Cancer Research. PMID 31948941 DOI: 10.1158/0008-5472.Can-19-2039 |
0.314 |
|
| 2020 |
Vasan N, Razavi P, Johnson JL, Shao H, Wilson T, Schimmoller F, Shah H, Antoine A, Ladewig E, Gorelick A, Lin T, Toska E, Xu G, Kazmi A, Chang MT, ... ... Rabadan R, et al. Abstract P3-03-01: Double PIK3CA mutations in cis drive oncogene addiction and enhance sensitivity to PI3K alpha inhibitors in breast cancer Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P3-03-01 |
0.339 |
|
| 2020 |
Affo S, Ravichandra A, Brundu F, Chin L, Rabadan R, Wells RG, Chen X, Schwabe RF. 460 Single Cell Rna Sequencing Analysis Unveils Cancer-Associate Fibroblasts Heterogeneity In Intrahepatic Cholangiocarcinoma Gastroenterology. 158. DOI: 10.1016/S0016-5085(20)33861-0 |
0.3 |
|
| 2019 |
Han S, Shin H, Lee JK, Liu Z, Rabadan R, Lee J, Shin J, Lee C, Yang H, Kim D, Kim SH, Kim J, Oh JW, Kong DS, Lee JI, et al. Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target. Experimental & Molecular Medicine. 51: 147. PMID 31811117 DOI: 10.1038/S12276-019-0351-Y |
0.311 |
|
| 2019 |
Sa JK, Hwang JR, Cho YJ, Ryu JY, Choi JJ, Jeong SY, Kim J, Kim MS, Paik ES, Lee YY, Choi CH, Kim TJ, Kim BG, Bae DS, Lee Y, ... ... Rabadan R, et al. Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers. Genome Biology. 20: 253. PMID 31771620 DOI: 10.1186/S13059-019-1848-3 |
0.34 |
|
| 2019 |
Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E, Anderson KJ, Abiola O, Aldape K, Alfaro KD, Alpar D, Amin SB, Ashley DM, Bandopadhayay P, Barnholtz-Sloan JS, ... ... Rabadan R, et al. Longitudinal molecular trajectories of diffuse glioma in adults. Nature. PMID 31748746 DOI: 10.1038/S41586-019-1775-1 |
0.35 |
|
| 2019 |
Vasan N, Razavi P, Johnson JL, Shao H, Shah H, Antoine A, Ladewig E, Gorelick A, Lin TY, Toska E, Xu G, Kazmi A, Chang MT, Taylor BS, Dickler MN, ... ... Rabadan R, et al. Double mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors. Science (New York, N.Y.). 366: 714-723. PMID 31699932 DOI: 10.1126/Science.Aaw9032 |
0.35 |
|
| 2019 |
Zhang J, Ali AM, Lieu YK, Liu Z, Gao J, Rabadan R, Raza A, Mukherjee S, Manley JL. Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1. Molecular Cell. PMID 31474574 DOI: 10.1016/J.Molcel.2019.07.017 |
0.327 |
|
| 2019 |
Scuoppo C, Wang J, Persaud M, Mittan SK, Basso K, Pasqualucci L, Rabadan R, Inghirami G, Grandori C, Bosch F, Dalla-Favera R. Repurposing dasatinib for diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 31383760 DOI: 10.1073/Pnas.1905239116 |
0.303 |
|
| 2019 |
Nam AS, Kim KT, Chaligne R, Izzo F, Ang C, Taylor J, Myers RM, Abu-Zeinah G, Brand R, Omans ND, Alonso A, Sheridan C, Mariani M, Dai X, Harrington E, ... ... Rabadan R, et al. Somatic mutations and cell identity linked by Genotyping of Transcriptomes. Nature. PMID 31270458 DOI: 10.1038/S41586-019-1367-0 |
0.384 |
|
| 2019 |
Blasco MT, Navas C, Martín-Serrano G, Graña-Castro O, Lechuga CG, Martín-Díaz L, Djurec M, Li J, Morales-Cacho L, Esteban-Burgos L, Perales-Patón J, Bousquet-Mur E, Castellano E, Jacob HKC, Cabras L, et al. Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF. Cancer Cell. PMID 30975481 DOI: 10.1016/J.Ccell.2019.03.002 |
0.341 |
|
| 2019 |
Zhao J, Chen AX, Gartrell RD, Silverman AM, Aparicio L, Chu T, Bordbar D, Shan D, Samanamud J, Mahajan A, Filip I, Orenbuch R, Goetz M, Yamaguchi JT, Cloney M, ... ... Rabadan R, et al. Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma. Nature Medicine. PMID 30742119 DOI: 10.1038/S41591-019-0349-Y |
0.323 |
|
| 2019 |
Anzalone AV, Zairis S, Lin AJ, Rabadan R, Cornish VW. Interrogation of eukaryotic stop codon readthrough signals by in vitro RNA selection. Biochemistry. PMID 30698415 DOI: 10.1021/Acs.Biochem.8B01280 |
0.304 |
|
| 2019 |
Cesarman E, Roshal M, Reichel J, Florian W, Binder B, Zairis S, Sadek J, Brody J, Rabadan R, Dave S. RNA Sequencing of Hodgkin Lymphoma Reed-Sternberg Cells Uncovers a Plasma Cell Signature and Escape from NK Cell Recognition Blood. 134: 549-549. DOI: 10.1182/Blood-2019-131163 |
0.349 |
|
| 2019 |
Chen AX, Gartrell R, Marks DK, Hart T, Rizk E, Monod A, Rabadan R, Saenger Y. Abstract B005: Linking transcriptomic and imaging features of the melanoma tumor microenvironment Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B005 |
0.351 |
|
| 2019 |
Vasan N, Razavi P, Johnson J, Shao H, Shah H, Antoine A, Ladewig E, Gorelick A, Toska E, Xu G, Kazmi A, Chang MT, Taylor BS, Dickler MN, Jhaveri K, ... Rabadan R, et al. Abstract 3917: DoublePIK3CAmutations incisenhance oncogene activation and sensitivity to PI3K alpha inhibitors in breast cancer Cancer Research. 79: 3917-3917. DOI: 10.1158/1538-7445.Am2019-3917 |
0.347 |
|
| 2019 |
Robert Kane J, Zhao J, Tsujiuchi T, Laffleur B, Mahajan A, Rao G, Mela A, Dmello C, Arrieta VA, Chen L, Zhang DY, Lee-Chang C, Xiao T, Rothschild G, Basu U, ... ... Rabadan R, et al. IMMU-42. CD8+ T-CELLS MEDIATE IMMUNOEDITING, AND INFLUENCE GENOTYPE, TUMOR ONCOGENIC PATHWAYS AND MICROENVIRONMENT DURING PROGRESSION OF MURINE GLIOMAS Neuro-Oncology. 21: vi128-vi128. DOI: 10.1093/Neuonc/Noz175.534 |
0.321 |
|
| 2019 |
Galan-Diez M, Zhao J, Rabadan R, Kousteni S. 2003 - Acute Myeloid Leukemia Cells Seize Serotonin Signaling In Osteoblasts To Engraft And Proliferate Experimental Hematology. 76. DOI: 10.1016/J.Exphem.2019.06.278 |
0.316 |
|
| 2018 |
Wendorff AA, Quinn SA, Rashkovan M, Madubata CJ, Ambesi-Impiombato A, Litzow MR, Tallman MS, Paietta E, Paganin M, Basso G, Gastier-Foster JM, Loh ML, Rabadan R, Van Vlierberghe P, Ferrando AA. Phf6 loss enhances HSC self-renewal driving tumor initiation and leukemia stem cell activity in T-ALL. Cancer Discovery. PMID 30567843 DOI: 10.1158/2159-8290.Cd-18-1005 |
0.321 |
|
| 2018 |
Sa JK, Choi SW, Zhao J, Lee Y, Zhang J, Kong DS, Choi JW, Seol HJ, Lee JI, Iavarone A, Rabadan R, Nam DH. Hypermutagenesis in untreated adult gliomas due to inherited mismatch mutations. International Journal of Cancer. PMID 30536544 DOI: 10.1002/Ijc.32054 |
0.373 |
|
| 2018 |
Youn A, Kim KI, Rabadan R, Tycko B, Shen Y, Wang S. A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes. Bmc Medical Genomics. 11: 98. PMID 30400878 DOI: 10.1186/S12920-018-0425-Z |
0.32 |
|
| 2018 |
Sapienza MR, Abate F, Melle F, Orecchioni S, Fuligni F, Etebari M, Tabanelli V, Laginestra MA, Pileri A, Motta G, Rossi M, Agostinelli C, Sabattini E, Pimpinelli N, Truni M, ... ... Rabadan R, et al. Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target. Haematologica. PMID 30381297 DOI: 10.3324/Haematol.2018.202093 |
0.382 |
|
| 2018 |
Lee JK, Liu Z, Sa JK, Shin S, Wang J, Bordyuh M, Cho HJ, Elliott O, Chu T, Choi SW, Rosenbloom DIS, Lee IH, Shin YJ, Kang HJ, Kim D, ... ... Rabadan R, et al. Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy. Nature Genetics. PMID 30262818 DOI: 10.1038/S41588-018-0209-6 |
0.343 |
|
| 2018 |
Rabadan R, Bhanot G, Marsilio S, Chiorazzi N, Pasqualucci L, Khiabanian H. On statistical modeling of sequencing noise in high depth data to assess tumor evolution. Journal of Statistical Physics. 172: 143-155. PMID 30034030 DOI: 10.1007/S10955-017-1945-1 |
0.342 |
|
| 2018 |
Pavlovich SS, Lovett SP, Koroleva G, Guito JC, Arnold CE, Nagle ER, Kulcsar K, Lee A, Thibaud-Nissen F, Hume AJ, Mühlberger E, Uebelhoer LS, Towner JS, Rabadan R, Sanchez-Lockhart M, et al. The Egyptian Rousette Genome Reveals Unexpected Features of Bat Antiviral Immunity. Cell. PMID 29706541 DOI: 10.1016/J.Cell.2018.03.070 |
0.327 |
|
| 2018 |
Tiacci E, Ladewig E, Schiavoni G, Penson A, Fortini E, Pettirossi V, Wang Y, Rosseto A, Venanzi A, Vlasevska S, Pacini R, Piattoni S, Tabarrini A, Pucciarini A, Bigerna B, ... ... Rabadan R, et al. Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma. Blood. PMID 29650799 DOI: 10.1182/Blood-2017-11-814913 |
0.411 |
|
| 2018 |
Arnes L, Liu Z, Wang J, Maurer HC, Sagalovskiy I, Sanchez-Martin M, Bommakanti N, Garofalo DC, Balderes DA, Sussel L, Olive KP, Rabadan R. Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma. Gut. PMID 29440233 DOI: 10.1136/Gutjnl-2017-314353 |
0.326 |
|
| 2018 |
Raponi S, Del Giudice I, Marinelli M, Wang J, Cafforio L, Ilari C, Piciocchi A, Messina M, Bonina S, Tavolaro S, Bordyuh M, Mariglia P, Peragine N, Mauro FR, Chiaretti S, ... ... Rabadan R, et al. Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 29365086 DOI: 10.1093/Annonc/Mdy021 |
0.324 |
|
| 2018 |
Djurec M, Graña O, Lee A, Troulé K, Espinet E, Cabras L, Navas C, Blasco MT, Martín-Díaz L, Burdiel M, Li J, Liu Z, Vallespinós M, Sanchez-Bueno F, Sprick MR, ... ... Rabadan R, et al. Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors. Proceedings of the National Academy of Sciences of the United States of America. PMID 29351990 DOI: 10.1073/Pnas.1717802115 |
0.336 |
|
| 2018 |
Tzoneva G, Dieck CL, Oshima K, Ambesi-Impiombato A, Sánchez-Martín M, Madubata CJ, Khiabanian H, Yu J, Waanders E, Iacobucci I, Sulis ML, Kato M, Koh K, Paganin M, Basso G, ... ... Rabadan R, et al. Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia. Nature. PMID 29342136 DOI: 10.1038/Nature25186 |
0.353 |
|
| 2018 |
Nam AS, Kim K, Chaligne R, Izzo F, Ang C, Omans N, Pastore A, Taylor J, Alonso A, Tam W, Hoffman R, Scandura J, Rabadan R, Abdel-Wahab OI, Smibert P, et al. High Throughput Droplet Single-Cell Genotyping of Transcriptomes (GoT) Reveals the Cell Identity Dependency of the Transcriptional Output of Somatic Mutations Blood. 132: 541-541. DOI: 10.1182/Blood-2018-99-119236 |
0.38 |
|
| 2018 |
Yoshimi A, Liu Z, Jiguang W, Cho H, Lee SC, Ki M, Bitner LE, Chu T, Mato AR, Ruvolo PP, Fabbri G, Pasqualucci L, Rabadan R, Abdel-Wahab OI. Mutations in the RNA Splicing Factor SF3B1 Promote Transformation through MYC Stabilization Blood. 132: 882-882. DOI: 10.1182/Blood-2018-99-110328 |
0.379 |
|
| 2018 |
Gartrell RD, Chen A, Marks DK, Hart TD, Li G, Wu A, Lu Y, Esancy C, Blake Z, Taback B, Rabadan R, Kaufman HL, Drake CG, Horst B, Monod A, et al. Abstract 2091: Quantitative compositional and spatial analysis of tumor microenvironment (TME) in primary melanoma Cancer Research. 78: 2091-2091. DOI: 10.1158/1538-7445.Am2018-2091 |
0.306 |
|
| 2018 |
Anghileri E, Zhao J, Eoli M, Langella T, Pollo B, Indraccolo S, Pellegatta S, Iavarone A, Rabadan R, Finocchiaro G. P01.150 hypermutations in glioblastoma are associated with increased response to immunotherapy Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy139.192 |
0.307 |
|
| 2017 |
Madubata CJ, Roshan-Ghias A, Chu T, Resnick S, Zhao J, Arnes L, Wang J, Rabadan R. Identification of potentially oncogenic alterations from tumor-only samples reveals Fanconi anemia pathway mutations in bladder carcinomas. Npj Genomic Medicine. 2: 29. PMID 29263839 DOI: 10.1038/S41525-017-0032-5 |
0.371 |
|
| 2017 |
Marsilio S, Khiabanian H, Fabbri G, Vergani S, Scuoppo C, Montserrat E, Shpall EJ, Hadigol M, Marin P, Rai KR, Rabadan R, Devereux S, Pasqualucci L, Chiorazzi N. Somatic CLL mutations occur at multiple distinct hematopoietic maturation stages: documentation and cautionary note regarding cell fraction purity. Leukemia. 32: 1041-1044. PMID 29203856 DOI: 10.1038/Leu.2017.343 |
0.319 |
|
| 2017 |
Gong Q, Wang C, Zhang W, Iqbal J, Hu Y, Greiner TC, Cornish A, Kim JH, Rabadan R, Abate F, Wang X, Inghirami GG, McKeithan TW, Chan WC. Assessment of T-cell receptor repertoire and clonal expansion in peripheral T-cell lymphoma using RNA-seq data. Scientific Reports. 7: 11301. PMID 28900149 DOI: 10.1038/S41598-017-11310-0 |
0.321 |
|
| 2017 |
Varano G, Raffel S, Sormani M, Zanardi F, Lonardi S, Zasada C, Perucho L, Petrocelli V, Haake A, Lee AK, Bugatti M, Paul U, Van Anken E, Pasqualucci L, Rabadan R, et al. The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3β inhibition. Nature. PMID 28562582 DOI: 10.1038/Nature22353 |
0.336 |
|
| 2017 |
Pappas K, Xu J, Zairis S, Resnick-Silverman L, Abate F, Steinbach N, Ozturk S, Saal LH, Su T, Cheung P, Schmidt H, Aaronson SA, Hibshoosh H, Manfredi JJ, Rabadan R, et al. p53 maintains baseline expression of multiple tumor suppressor genes. Molecular Cancer Research : McR. PMID 28483946 DOI: 10.1158/1541-7786.Mcr-17-0089 |
0.347 |
|
| 2017 |
Lee JK, Wang J, Sa JK, Ladewig E, Lee HO, Lee IH, Kang HJ, Rosenbloom DS, Camara PG, Liu Z, Nieuwenhuizen PV, Jung SW, Choi SW, Kim J, Chen A, ... ... Rabadan R, et al. Spatiotemporal genomic architecture informs precision oncology in glioblastoma. Nature Genetics. PMID 28263318 DOI: 10.1038/Ng.3806 |
0.352 |
|
| 2017 |
Abate F, da Silva-Almeida AC, Zairis S, Robles-Valero J, Couronne L, Khiabanian H, Quinn SA, Kim MY, Laginestra MA, Kim C, Fiore D, Bhagat G, Piris MA, Campo E, Lossos IS, ... ... Rabadan R, et al. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America. PMID 28062691 DOI: 10.1073/Pnas.1608839114 |
0.373 |
|
| 2017 |
Scuoppo C, Jiguang W, Persaud M, Mittan S, Pasqualucci L, Rabadan R, Grandori C, Dalla-Favera R. Repurposing dasatinib for ibrutinib-resistant diffuse large B-Cell lymphoma Blood. 130: 3843-3843. DOI: 10.1182/Blood.V130.Suppl_1.3843.3843 |
0.323 |
|
| 2016 |
Rosenbloom DI, Camara PG, Chu T, Rabadan R. Evolutionary scalpels for dissecting tumor ecosystems. Biochimica Et Biophysica Acta. PMID 27923679 DOI: 10.1016/J.Bbcan.2016.11.005 |
0.323 |
|
| 2016 |
Melamed RD, Aydin IT, Rajan GS, Phelps R, Silvers DN, Emmett KJ, Brunner G, Rabadan R, Celebi JT. Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis of Melanoma. The Journal of Investigative Dermatology. PMID 27890785 DOI: 10.1016/J.Jid.2016.11.017 |
0.382 |
|
| 2016 |
Oshima K, Khiabanian H, da Silva-Almeida AC, Tzoneva G, Abate F, Ambesi-Impiombato A, Sanchez-Martin M, Carpenter Z, Penson A, Perez-Garcia A, Eckert C, Nicolas C, Balbin M, Sulis ML, Kato M, ... ... Rabadan R, et al. Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America. PMID 27655895 DOI: 10.1182/Blood.V128.22.4068.4068 |
0.322 |
|
| 2016 |
Cámara PG, Levine AJ, Rabadán R. Inference of Ancestral Recombination Graphs through Topological Data Analysis. Plos Computational Biology. 12: e1005071. PMID 27532298 DOI: 10.1371/Journal.Pcbi.1005071 |
0.328 |
|
| 2016 |
Camara PG, Rosenbloom DI, Emmett KJ, Levine AJ, Rabadan R. Topological Data Analysis Generates High-Resolution, Genome-wide Maps of Human Recombination. Cell Systems. PMID 27345159 DOI: 10.1016/J.Cels.2016.05.008 |
0.303 |
|
| 2016 |
Spina V, Khiabanian H, Messina M, Monti S, Cascione L, Bruscaggin A, Spaccarotella E, Holmes AB, Arcaini L, Lucioni M, Tabbò F, Zairis S, Diop F, Cerri M, Chiaretti S, ... ... Rabadan R, et al. The genetics of nodal marginal zone lymphoma. Blood. PMID 27335277 DOI: 10.1016/J.Clml.2016.07.149 |
0.386 |
|
| 2016 |
Yamamoto K, Wang J, Sprinzen L, Xu J, Haddock CJ, Li C, Lee BJ, Loredan DG, Jiang W, Vindigni A, Wang D, Rabadan R, Zha S. Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo-isomerase I inhibitors. Elife. 5. PMID 27304073 DOI: 10.7554/Elife.14709 |
0.32 |
|
| 2016 |
Wang J, Cazzato E, Ladewig E, Frattini V, Rosenbloom DI, Zairis S, Abate F, Liu Z, Elliott O, Shin YJ, Lee JK, Lee IH, Park WY, Eoli M, Blumberg AJ, ... ... Rabadan R, et al. Clonal evolution of glioblastoma under therapy. Nature Genetics. PMID 27270107 DOI: 10.1038/Ng.3590 |
0.361 |
|
| 2016 |
Paganin M, Buldini B, Germano G, Seganfreddo E, Meglio AD, Magrin E, Grillo F, Pigazzi M, Rizzari C, Cazzaniga G, Khiabanian H, Palomero T, Rabadan R, Ferrando AA, Basso G. A Case of T-cell Acute Lymphoblastic Leukemia Relapsed As Myeloid Acute Leukemia. Pediatric Blood & Cancer. PMID 27149388 DOI: 10.1002/Pbc.26054 |
0.302 |
|
| 2016 |
Messina M, Chiaretti S, Wang J, Fedullo AL, Peragine N, Gianfelici V, Piciocchi A, Brugnoletti F, Di Giacomo F, Pauselli S, Holmes AB, Puzzolo MC, Ceglie G, Apicella V, Mancini M, ... ... Rabadan R, et al. Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes. Oncotarget. PMID 26883104 DOI: 10.18632/Oncotarget.7356 |
0.354 |
|
| 2016 |
Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA, Morozova O, Newton Y, Radenbaugh A, Pagnotta SM, Anjum S, Wang J, Manyam G, Zoppoli P, Ling S, ... ... Rabadan R, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 164: 550-563. PMID 26824661 DOI: 10.1016/J.Cell.2015.12.028 |
0.344 |
|
| 2016 |
Rasi S, Khiabanian H, Ciardullo C, Terzi-di-Bergamo L, Monti S, Spina V, Bruscaggin A, Cerri M, Deambrogi C, Martuscelli L, Biasi A, Spaccarotella E, De Paoli L, Gattei V, Foa' R, ... Rabadan R, et al. CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA. Haematologica. PMID 26819056 DOI: 10.3324/Haematol.2015.136051 |
0.343 |
|
| 2016 |
Wang J, Kribelbauer J, Rabadan R. Network propagation reveals novel features predicting drug response of cancer cell lines Current Bioinformatics. 11: 203-210. DOI: 10.2174/1574893611666160125222144 |
0.324 |
|
| 2016 |
Palomero T, Abate F, da Silva Almeida AC, Zairis S, Robles-Valero J, Couronne L, Khiabanian H, Quinn SA, Kim M, Laginestra MA, Kim CS, Fiore D, Bhagat G, Piris MAA, Campo E, ... ... Rabadan R, et al. VAV1 Activating Mutations and Translocations in Peripheral T-Cell Lymphomas Blood. 128: 2741-2741. DOI: 10.1182/Blood.V128.22.2741.2741 |
0.384 |
|
| 2016 |
Tiacci E, Penson A, Schiavoni G, Ladewig E, Fortini E, Wang Y, Spanhol-Rosseto A, Venanzi A, Gianni AM, Viviani S, Cabras A, Crescenzi B, Mecucci C, Pasqualucci L, Rabadan R, et al. New Recurrently Mutated Genes in Classical Hodgkin Lymphoma Revealed By Whole-Exome Sequencing of Microdissected Tumor Cells Blood. 128: 1088-1088. DOI: 10.1182/Blood.V128.22.1088.1088 |
0.407 |
|
| 2016 |
Schoenfeld D, Su W, Zairis S, Mathur D, Rabadan R, Parsons R. Abstract A24: PBRM1 alteration in clear cell renal cell carcinoma increases tumorigenicity through ALDH1A1 upregulation Cancer Research. 76. DOI: 10.1158/1538-7445.Chromepi15-A24 |
0.372 |
|
| 2015 |
Del Giudice I, Marinelli M, Wang J, Bonina S, Messina M, Chiaretti S, Ilari C, Cafforio L, Raponi S, Mauro FR, Di Maio V, De Propris MS, Nanni M, Ciardullo C, Rossi D, ... ... Rabadan R, et al. Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments. British Journal of Haematology. PMID 26597680 DOI: 10.1111/Bjh.13859 |
0.345 |
|
| 2015 |
da Silva Almeida AC, Abate F, Khiabanian H, Martinez-Escala E, Guitart J, Tensen CP, Vermeer MH, Rabadan R, Ferrando A, Palomero T. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome. Nature Genetics. 47: 1465-70. PMID 26551667 DOI: 10.1038/Ng.3442 |
0.383 |
|
| 2015 |
Abate F, Ambrosio MR, Mundo L, Laginestra MA, Fuligni F, Rossi M, Zairis S, Gazaneo S, De Falco G, Lazzi S, Bellan C, Rocca BJ, Amato T, Marasco E, Etebari M, ... ... Rabadan R, et al. Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma. Plos Pathogens. 11: e1005158. PMID 26468873 DOI: 10.1371/Journal.Ppat.1005158 |
0.382 |
|
| 2015 |
Scarfò I, Pellegrino E, Mereu E, Kwee I, Agnelli L, Bergaggio E, Garaffo G, Vitale N, Caputo M, Machiorlatti R, Circosta P, Abate F, Barreca A, Novero D, Mathew S, ... ... Rabadan R, et al. Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts. Blood. PMID 26463425 DOI: 10.1182/Blood-2014-12-614503 |
0.344 |
|
| 2015 |
Zhang J, Lieu YK, Ali AM, Penson A, Reggio KS, Rabadan R, Raza A, Mukherjee S, Manley JL. Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities. Proceedings of the National Academy of Sciences of the United States of America. PMID 26261309 DOI: 10.1073/Pnas.1514105112 |
0.325 |
|
| 2015 |
Melamed RD, Wang J, Iavarone A, Rabadan R. An information theoretic method to identify combinations of genomic alterations that promote glioblastoma. Journal of Molecular Cell Biology. 7: 203-13. PMID 25941339 DOI: 10.1093/Jmcb/Mjv026 |
0.405 |
|
| 2015 |
Melamed RD, Emmett KJ, Madubata C, Rzhetsky A, Rabadan R. Genetic similarity between cancers and comorbid Mendelian diseases identifies candidate driver genes. Nature Communications. 6: 7033. PMID 25926297 DOI: 10.1038/Ncomms8033 |
0.31 |
|
| 2015 |
Crescenzo R, Abate F, Lasorsa E, Tabbo' F, Gaudiano M, Chiesa N, Di Giacomo F, Spaccarotella E, Barbarossa L, Ercole E, Todaro M, Boi M, Acquaviva A, Ficarra E, Novero D, ... ... Rabadan R, et al. Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell. 27: 516-32. PMID 25873174 DOI: 10.1016/j.ccell.2015.03.006 |
0.409 |
|
| 2015 |
Emmett KJ, Lee A, Khiabanian H, Rabadan R. High-resolution Genomic Surveillance of 2014 Ebolavirus Using Shared Subclonal Variants. Plos Currents. 7. PMID 25737802 DOI: 10.1371/Currents.Outbreaks.C7Fd7946Ba606C982668A96Bcba43C90 |
0.307 |
|
| 2015 |
Abate F, Todaro M, van der Krogt JA, Boi M, Landra I, Machiorlatti R, Tabbò F, Messana K, Abele C, Barreca A, Novero D, Gaudiano M, Aliberti S, Di Giacomo F, Tousseyn T, ... ... Rabadan R, et al. A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation. Leukemia. 29: 1390-401. PMID 25533804 DOI: 10.1038/Leu.2014.347 |
0.371 |
|
| 2015 |
Palomero T, da Silva Almeida AC, Abate F, Khiabanian H, Martinez-Escala E, Guitart J, Tensen CP, Vermeer MH, Rabadan R, Ferrando AA. The Mutational Landscape of CTCL and Sezary Syndrome Blood. 126: 573-573. DOI: 10.1182/Blood.V126.23.573.573 |
0.386 |
|
| 2015 |
Thomas DH, Lee AK, Sastra SA, Palermo CF, Rabadan R, Kenneth PO. Abstract B11: Understanding how the Hedgehog pathway mediates stromal desmoplasia in Pancreatic Ductal Adencarcinoma Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-B11 |
0.344 |
|
| 2015 |
Djurec M, Grana O, Pisano D, Lee A, Rabadan R, Guerra C, Barbacid M. Abstract A44: Targeting cancer-associated fibroblasts in pancreatic ductal adenocarcinoma: Identification and characterization of therapeutic candidates Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-A44 |
0.371 |
|
| 2015 |
Reichel J, Brody J, Elemento O, Rabadan R, Cesarman E. Abstract 4750: Transcriptome sequencing of the Reed-Sternberg cells of classical Hodgkin lymphoma Cancer Research. 75: 4750-4750. DOI: 10.1158/1538-7445.Am2015-4750 |
0.363 |
|
| 2015 |
Wang Q, Hu X, Muller F, Kim H, Mikkelsen T, Scarpace L, Lin Y, Satani N, Chang E, Olar A, Decarvalho A, Eskilsson E, Rabadan R, Iavarone A, Finocchiaro G, et al. MTR-19A MACROPHAGE-/MICROGLIAL-RICH TUMOR MICROENVIRONMENT MIMICS PRONEURAL TO MESENCHYMAL TRANSITION IN GLIOBLASTOMA Neuro-Oncology. 17: v128.3-v128. DOI: 10.1093/Neuonc/Nov219.19 |
0.331 |
|
| 2015 |
Barthel FP, Ceccarelli M, Malta TM, Sabedot TS, Salama SR, Pagnotta SM, Murray BA, Morozova O, Newton Y, Brat DJ, Cherniack AD, Zhang H, Poisson L, Cooper L, Rabadan R, et al. GENO-06A PAN-GLIOMA CHARACTERIZATION OF GENOMIC, EPIGENOMIC AND TRANSCRIPTOMIC ACTIVITIES REVEALS NOVEL RELATIONSHIPS BETWEEN HISTOLOGICAL SUBTYPES AND MOLECULAR SIGNATURES Neuro-Oncology. 17: v92.2-v92. DOI: 10.1093/Neuonc/Nov215.06 |
0.377 |
|
| 2015 |
Crescenzo R, Abate F, Lasorsa E, Tabbo F, Gaudiano M, Chiesa N, Giacomo FD, Spaccarotella E, Barbarossa L, Ercole E, Todaro M, Boi M, Acquaviva A, Ficarra E, Novero D, ... ... Rabadan R, et al. Erratum to Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma [Cancer Cell 27, 516-532] April 13, 2015 10.1016/j.ccell.2015.04.014 Cancer Cell. 27. DOI: 10.1016/J.Ccell.2015.04.014 |
0.343 |
|
| 2014 |
Wang J, Khiabanian H, Rossi D, Fabbri G, Gattei V, Forconi F, Laurenti L, Marasca R, Del Poeta G, Foà R, Pasqualucci L, Gaidano G, Rabadan R. Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia. Elife. 3. PMID 25496728 DOI: 10.7554/Elife.02869 |
0.332 |
|
| 2014 |
Abate F, Zairis S, Ficarra E, Acquaviva A, Wiggins CH, Frattini V, Lasorella A, Iavarone A, Inghirami G, Rabadan R. Pegasus: a comprehensive annotation and prediction tool for detection of driver gene fusions in cancer. Bmc Systems Biology. 8: 97. PMID 25183062 DOI: 10.1186/S12918-014-0097-Z |
0.324 |
|
| 2014 |
Pefanis E, Wang J, Rothschild G, Lim J, Chao J, Rabadan R, Economides AN, Basu U. Noncoding RNA transcription targets AID to divergently transcribed loci in B cells. Nature. 514: 389-93. PMID 25119026 DOI: 10.1038/Nature13580 |
0.305 |
|
| 2014 |
Aydin IT, Melamed RD, Adams SJ, Castillo-Martin M, Demir A, Bryk D, Brunner G, Cordon-Cardo C, Osman I, Rabadan R, Celebi JT. FBXW7 mutations in melanoma and a new therapeutic paradigm. Journal of the National Cancer Institute. 106: dju107. PMID 24838835 DOI: 10.1093/Jnci/Dju107 |
0.326 |
|
| 2014 |
Messina M, Del Giudice I, Khiabanian H, Rossi D, Chiaretti S, Rasi S, Spina V, Holmes AB, Marinelli M, Fabbri G, Piciocchi A, Mauro FR, Guarini A, Gaidano G, Dalla-Favera R, ... ... Rabadan R, et al. Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness. Blood. 123: 2378-88. PMID 24550227 DOI: 10.1182/Blood-2013-10-534271 |
0.399 |
|
| 2014 |
Rossi D, Khiabanian H, Spina V, Ciardullo C, Bruscaggin A, Famà R, Rasi S, Monti S, Deambrogi C, De Paoli L, Wang J, Gattei V, Guarini A, Foà R, Rabadan R, et al. Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia. Blood. 123: 2139-47. PMID 24501221 DOI: 10.1182/Blood-2013-11-539726 |
0.373 |
|
| 2014 |
Kode A, Manavalan JS, Mosialou I, Bhagat G, Rathinam CV, Luo N, Khiabanian H, Lee A, Murty VV, Friedman R, Brum A, Park D, Galili N, Mukherjee S, Teruya-Feldstein J, ... ... Rabadan R, et al. Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts. Nature. 506: 240-4. PMID 24429522 DOI: 10.1038/Nature12883 |
0.32 |
|
| 2014 |
Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB, Ouillette P, Trifonov V, Rossi D, Tabbò F, Ponzoni M, Chadburn A, Murty VV, Bhagat G, Gaidano G, ... ... Rabadan R, et al. Genetics of follicular lymphoma transformation. Cell Reports. 6: 130-40. PMID 24388756 DOI: 10.1016/J.Celrep.2013.12.027 |
0.382 |
|
| 2014 |
Spina V, Khiabanian H, Bruscaggin A, Messina M, Monti S, Holmes AB, Chiaretti S, Famà R, Arcaini L, Lucioni M, Tabbò F, Cresta S, Rasi S, Zairis S, Ramponi A, ... ... Rabadan R, et al. The Coding Genome of Nodal Marginal Zone Lymphoma Reveals Recurrent Molecular Alterations of PTPRD and Other Jak/Stat Signaling Genes Blood. 124: 705-705. DOI: 10.1182/Blood.V124.21.705.705 |
0.403 |
|
| 2014 |
Ali AM, Iverson N, Penson A, Scott A, Riaz T, Rabadan R, Mukherjee S, Raza A. Molecular Genetic Analysis of Myelodysplastic Syndromes (MDS) Patients with Ring Sideroblasts (RS); Independent Confirmation of Association of SF3B1 Mutations with Better Prognosis Blood. 124: 3237-3237. DOI: 10.1182/Blood.V124.21.3237.3237 |
0.346 |
|
| 2014 |
Rossi D, Khiabanian H, Rasi S, Ciardullo C, Terzi di Bergamo L, Monti S, Spina V, Biasi A, De Paoli L, Gattei V, Foà R, Rabadan R, Gaidano G. Small Subclones Harboring NOTCH1, SF3B1 or BIRC3 Mutations Are Clinically Irrelevant in Chronic Lymphocytic Leukemia Blood. 124: 295-295. DOI: 10.1182/Blood.V124.21.295.295 |
0.372 |
|
| 2014 |
Scarfò I, Pellegrino E, Kwee I, Agnelli L, Mereu E, Bergaggio E, Abate F, Machiorlatti R, Messana K, Rinaldi A, Tiacci E, Serra S, Deaglio S, Neri A, Falini B, ... Rabadan R, et al. Identification of a New Subclass of ALK Negative Anaplastic Large Cell Lymphoma Expressing Aberrant Levels of ERBB4 Transcripts Blood. 124: 1679-1679. DOI: 10.1182/Blood.V124.21.1679.1679 |
0.346 |
|
| 2013 |
Trifonov V, Pasqualucci L, Tiacci E, Falini B, Rabadan R. SAVI: a statistical algorithm for variant frequency identification. Bmc Systems Biology. 7: S2. PMID 24564980 DOI: 10.1186/1752-0509-7-S2-S2 |
0.31 |
|
| 2013 |
Frattini V, Trifonov V, Chan JM, Castano A, Lia M, Abate F, Keir ST, Ji AX, Zoppoli P, Niola F, Danussi C, Dolgalev I, Porrati P, Pellegatta S, Heguy A, ... ... Rabadan R, et al. The integrated landscape of driver genomic alterations in glioblastoma. Nature Genetics. 45: 1141-9. PMID 23917401 DOI: 10.1038/Ng.2734 |
0.376 |
|
| 2013 |
Tabbò F, Ponzoni M, Rabadan R, Bertoni F, Inghirami G. Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis: alternative drivers in anaplastic large cell lymphoma. Current Opinion in Hematology. 20: 374-81. PMID 23673339 DOI: 10.1097/Moh.0B013E3283623C07 |
0.312 |
|
| 2013 |
Trifonov V, Pasqualucci L, Dalla Favera R, Rabadan R. MutComFocal: an integrative approach to identifying recurrent and focal genomic alterations in tumor samples. Bmc Systems Biology. 7: 25. PMID 23531283 DOI: 10.1186/1752-0509-7-25 |
0.361 |
|
| 2013 |
Tzoneva G, Perez-Garcia A, Carpenter Z, Khiabanian H, Tosello V, Allegretta M, Paietta E, Racevskis J, Rowe JM, Tallman MS, Paganin M, Basso G, Hof J, Kirschner-Schwabe R, Palomero T, ... Rabadan R, et al. Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL. Nature Medicine. 19: 368-71. PMID 23377281 DOI: 10.1038/Nm.3078 |
0.349 |
|
| 2013 |
Chan JM, Rabadan R. Quantifying pathogen surveillance using temporal genomic data. Mbio. 4: e00524-12. PMID 23362319 DOI: 10.1128/Mbio.00524-12 |
0.319 |
|
| 2013 |
Rossi D, Rasi S, Spina V, Bruscaggin A, Monti S, Ciardullo C, Deambrogi C, Khiabanian H, Serra R, Bertoni F, Forconi F, Laurenti L, Marasca R, Dal-Bo M, Rossi FM, ... ... Rabadan R, et al. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. Blood. 121: 1403-12. PMID 23243274 DOI: 10.1182/Blood-2012-09-458265 |
0.336 |
|
| 2013 |
Yang Y, Wu J, Demir A, Castillo-Martin M, Melamed RD, Zhang G, Fukunaga-Kanabis M, Perez-Lorenzo R, Zheng B, Silvers DN, Brunner G, Wang S, Rabadan R, Cordon-Cardo C, Celebi JT. GAB2 induces tumor angiogenesis in NRAS-driven melanoma Oncogene. 32: 3627-3637. PMID 22926523 DOI: 10.1038/Onc.2012.367 |
0.325 |
|
| 2013 |
Palomero T, Couronne L, Khiabanian H, Kim M, Ambesi A, Carpenter Z, Abate F, Allegretta M, Lossos IS, Nicolas C, Balbin M, Bastard C, Bhagat G, Piris MAA, Campo E, ... ... Rabadan R, et al. Recurrent Rhoa Mutations In Peripheral T-Cell Lymphoma Blood. 122: 846-846. DOI: 10.1182/Blood.V122.21.846.846 |
0.381 |
|
| 2013 |
Couronne L, Palomero T, Khiabanian H, Kim M, Ambesi A, Carpenter Z, Abate F, Allegretta M, Lossos IS, Nicolas C, Balbin M, Bastard C, Bhagat G, Piris MA, Campo E, ... ... Rabadan R, et al. Activating Mutations In Fyn Kinase In Peripheral T-Cell Lymphomas Blood. 122: 811-811. DOI: 10.1182/Blood.V122.21.811.811 |
0.355 |
|
| 2013 |
Zhang J, Neupane R, Canoll P, Lieu Y, Mukherjee S, Rabadan R, Raza A, Manley JL. Abstract IA6: Misregulation of pre-mRNA splicing in cancer Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-Ia6 |
0.384 |
|
| 2013 |
Tzoneva G, Perez-Garcia A, Carpenter Z, Khiabanian H, Tosello V, Allegretta M, Paietta E, Racevkis J, Rowe JM, Tallman MS, Paganin M, Hoff J, Kirschner-Schwabe R, Palomero T, Rabadan R, et al. Abstract 4595: Activating mutations in theNT5C2nucleotidase gene drive chemotherapy resistance in relapsed ALL. Cancer Research. 73: 4595-4595. DOI: 10.1158/1538-7445.Am2013-4595 |
0.347 |
|
| 2013 |
Tabbo F, Barreca A, Machiorlatti R, Messana K, Landra I, Abate F, Boi M, Todaro M, Abele C, Novero D, Zamo A, Chilosi M, Ponzoni M, Cheng M, Ruggeri B, ... ... Rabadan R, et al. Abstract 3853: Humanized NOD/Scid/IL2g-/- tumor grafts recapitulate primary anaplastic large cell lymphoma. Cancer Research. 73: 3853-3853. DOI: 10.1158/1538-7445.Am2013-3853 |
0.345 |
|
| 2012 |
Rossi D, Trifonov V, Fangazio M, Bruscaggin A, Rasi S, Spina V, Monti S, Vaisitti T, Arruga F, Famà R, Ciardullo C, Greco M, Cresta S, Piranda D, Holmes A, ... ... Rabadan R, et al. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. The Journal of Experimental Medicine. 209: 1537-51. PMID 22891273 DOI: 10.1084/Jem.20120904 |
0.372 |
|
| 2012 |
Ntziachristos P, Tsirigos A, Van Vlierberghe P, Nedjic J, Trimarchi T, Flaherty MS, Ferres-Marco D, da Ros V, Tang Z, Siegle J, Asp P, Hadler M, Rigo I, De Keersmaecker K, Patel J, ... ... Rabadan R, et al. Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia. Nature Medicine. 18: 298-301. PMID 22237151 DOI: 10.1038/Nm.2651 |
0.337 |
|
| 2012 |
Rossi D, Rasi S, Fabbri G, Spina V, Fangazio M, Forconi F, Marasca R, Laurenti L, Bruscaggin A, Cerri M, Monti S, Cresta S, Famà R, De Paoli L, Bulian P, ... ... Rabadan R, et al. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood. 119: 521-9. PMID 22077063 DOI: 10.1182/Blood-2011-09-379966 |
0.336 |
|
| 2012 |
Galili N, Trifonov V, Ewalt M, Mukherjee S, Rabadan R, Raza A. Identification of Dido1 Mutation Associated with Familial Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML) Blood. 120: 169-169. DOI: 10.1182/Blood.V120.21.169.169 |
0.366 |
|
| 2011 |
Rossi D, Bruscaggin A, Spina V, Rasi S, Khiabanian H, Messina M, Fangazio M, Vaisitti T, Monti S, Chiaretti S, Guarini A, Del Giudice I, Cerri M, Cresta S, Deambrogi C, ... ... Rabadan R, et al. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood. 118: 6904-8. PMID 22039264 DOI: 10.1182/Blood-2011-08-373159 |
0.377 |
|
| 2011 |
Grossmann V, Tiacci E, Holmes AB, Kohlmann A, Martelli MP, Kern W, Spanhol-Rosseto A, Klein HU, Dugas M, Schindela S, Trifonov V, Schnittger S, Haferlach C, Bassan R, Wells VA, ... ... Rabadan R, et al. Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype. Blood. 118: 6153-63. PMID 22012066 DOI: 10.1182/Blood-2011-07-365320 |
0.36 |
|
| 2011 |
Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A, Wells VA, Grunn A, Messina M, Elliot O, Chan J, Bhagat G, Chadburn A, Gaidano G, Mullighan CG, ... Rabadan R, et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nature Genetics. 43: 830-7. PMID 21804550 DOI: 10.1038/Ng.892 |
0.366 |
|
| 2011 |
Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J, Grunn A, Fangazio M, Capello D, Monti S, Cresta S, Gargiulo E, Forconi F, Guarini A, Arcaini L, ... ... Rabadan R, et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. The Journal of Experimental Medicine. 208: 1389-401. PMID 21670202 DOI: 10.1084/Jem.20110921 |
0.39 |
|
| 2011 |
Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP, Pucciarini A, Bigerna B, Pacini R, Wells VA, Sportoletti P, Pettirossi V, Mannucci R, Elliott O, Liso A, ... ... Rabadan R, et al. BRAF mutations in hairy-cell leukemia. The New England Journal of Medicine. 364: 2305-15. PMID 21663470 DOI: 10.1056/Nejmoa1014209 |
0.375 |
|
| 2011 |
Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, Kasper LH, Lerach S, Tang H, Ma J, Rossi D, Chadburn A, Murty VV, Mullighan CG, Gaidano G, ... Rabadan R, et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature. 471: 189-95. PMID 21390126 DOI: 10.1038/Nature09730 |
0.367 |
|
| 2011 |
Jimenez-Baranda S, Greenbaum B, Manches O, Handler J, Rabadán R, Levine A, Bhardwaj N. Oligonucleotide motifs that disappear during the evolution of influenza virus in humans increase alpha interferon secretion by plasmacytoid dendritic cells. Journal of Virology. 85: 3893-904. PMID 21307198 DOI: 10.1128/Jvi.01908-10 |
0.309 |
|
| 2010 |
Baumeister E, Palacios G, Cisterna D, Solovyov A, Hui J, Savji N, Bussetti AV, Campos A, Pontoriero A, Jabado OJ, Street C, Hirschberg DL, Rabadan R, Alonio V, Molina V, et al. Molecular characterization of severe and mild cases of influenza A (H1N1) 2009 strain from Argentina. Medicina. 70: 518-23. PMID 21163739 DOI: 10.7916/D8Sq954P |
0.321 |
|
| 2010 |
Trifonov V, Rabadan R. Frequency analysis techniques for identification of viral genetic data. Mbio. 1. PMID 20824103 DOI: 10.1128/Mbio.00156-10 |
0.308 |
|
| 2010 |
Van Vlierberghe P, Palomero T, Khiabanian H, Van der Meulen J, Castillo M, Van Roy N, De Moerloose B, Philippé J, González-GarcÃa S, Toribio ML, Taghon T, Zuurbier L, Cauwelier B, Harrison CJ, Schwab C, ... ... Rabadan R, et al. PHF6 mutations in T-cell acute lymphoblastic leukemia. Nature Genetics. 42: 338-42. PMID 20228800 DOI: 10.1038/Ng.542 |
0.357 |
|
| 2010 |
Fabbri G, Trifonov V, Rossi D, Elliot OT, Chan JM, Rinaldi A, Kwee I, Bertoni F, Gaidano G, Pasqualucci L, Rabadan R, Dalla-Favera R. The Genome of Chronic Lymphocytic Leukemia Blood. 116: 51-51. DOI: 10.1182/Blood.V116.21.51.51 |
0.413 |
|
| 2010 |
Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, Kasper LH, Lerach S, Jing M, Rossi D, Mullighan C, Gaidano G, Rabadan R, Brindle PK, Dalla-Favera R. Genome-Wide Analysis Reveals Frequent Inactivating Mutations of Acetyltransferase Genes In B-Cell Lymphoma Blood. 116: 474-474. DOI: 10.1182/Blood.V116.21.474.474 |
0.389 |
|
| 2008 |
Krasnitz M, Levine AJ, Rabadan R. Anomalies in the influenza virus genome database: new biology or laboratory errors? Journal of Virology. 82: 8947-50. PMID 18579605 DOI: 10.1128/Jvi.00101-08 |
0.305 |
|
| 2008 |
Greenbaum BD, Levine AJ, Bhanot G, Rabadan R. Patterns of evolution and host gene mimicry in influenza and other RNA viruses. Plos Pathogens. 4: e1000079. PMID 18535658 DOI: 10.1371/Journal.Ppat.1000079 |
0.304 |
|
| 2008 |
Atwal GS, Rabadán R, Lozano G, Strong LC, Ruijs MW, Schmidt MK, van't Veer LJ, Nevanlinna H, Tommiska J, Aittomäki K, Bougeard G, Frebourg T, Levine AJ, Bond GL. An information-theoretic analysis of genetics, gender and age in cancer patients. Plos One. 3: e1951. PMID 18398474 DOI: 10.1371/Journal.Pone.0001951 |
0.325 |
|
| 2008 |
Marsh GA, Rabadán R, Levine AJ, Palese P. Highly conserved regions of influenza a virus polymerase gene segments are critical for efficient viral RNA packaging. Journal of Virology. 82: 2295-304. PMID 18094182 DOI: 10.1128/Jvi.02267-07 |
0.311 |
|
| 2006 |
Rabadan R, Levine AJ, Robins H. Comparison of avian and human influenza A viruses reveals a mutational bias on the viral genomes. Journal of Virology. 80: 11887-91. PMID 16987977 DOI: 10.1128/Jvi.01414-06 |
0.311 |
|
| Show low-probability matches. |